Contrast-induced nephropathy (CIN) is one of the most serious adverse events associated
with the use of contrast media (CM). Patients who develop this complication can have …

Contrast-induced nephropathy (CIN) is a serious, but potentially preventable adverse event
associated with the use of iodinated contrast media (CM). Studies suggest that the …

Objectives: Determine the incidence of patients at risk for contrast-induced nephropathy
(CIN), the incidence of CIN and mid-term effects (renal replacement therapy/death< one …

Recent improvements in contrast agents and radiologic imaging tools have resulted in an
increasing number of patients undergoing contrast media (CM)-enhanced examinations …

Contrast-induced nephropathy (CIN) is a leading cause of iatrogenic acute kidney failure.
Periprocedural CIN results in a greater risk of requiring renal replacement therapy …

Contrast-induced nephropathy (CIN) is associated with increased morbidity and mortality, as
well as increased costs for medical care, particularly in patients with diabetes mellitus and …

Contrast induced nephropathy (CIN) is an iatrogenic disorder, resulting from exposure to
contrast media. Contrast‐induced hemodynamic and direct cytotoxic effects on renal …

Purpose Contrast-induced acute kidney injury or contrast-induced nephropathy (CIN) is a
significant complication of intravascular contrast medium (CM). These guidelines are …

Objective: Contrast-induced nephropathy (CIN) is a complication which may develop after
exposure to iodinated contrast media. The resulting acute kidney injury (AKI) is associated …

Contrast-induced nephropathy (CIN) represents an important adverse effect of contrast
media (CM) administration. Contrast-induced nephropathy is associated with prolonged …